Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

ABI-008 Trial in Patients With Metastatic Breast Cancer

This study has been terminated.
Sponsor:
Information provided by:
Celgene Corporation
ClinicalTrials.gov Identifier:
NCT00531271
First received: September 14, 2007
Last updated: June 11, 2009
Last verified: June 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2008
  Estimated Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)